Does RIOCIGUAT Cause Mobility decreased? 64 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Mobility decreased have been filed in association with RIOCIGUAT (Adempas). This represents 0.4% of all adverse event reports for RIOCIGUAT.
64
Reports of Mobility decreased with RIOCIGUAT
0.4%
of all RIOCIGUAT reports
5
Deaths
38
Hospitalizations
How Dangerous Is Mobility decreased From RIOCIGUAT?
Of the 64 reports, 5 (7.8%) resulted in death, 38 (59.4%) required hospitalization, and 2 (3.1%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIOCIGUAT. However, 64 reports have been filed with the FAERS database.
What Other Side Effects Does RIOCIGUAT Cause?
Death (4,500)
Dyspnoea (2,881)
Headache (2,462)
Dizziness (2,208)
Hypotension (2,192)
Nausea (2,020)
Hospitalisation (1,864)
Diarrhoea (1,790)
Fatigue (1,638)
Vomiting (1,124)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which RIOCIGUAT Alternatives Have Lower Mobility decreased Risk?
RIOCIGUAT vs RIPRETINIB
RIOCIGUAT vs RISANKIZUMAB
RIOCIGUAT vs RISANKIZUMAB-RZAA
RIOCIGUAT vs RISDIPLAM
RIOCIGUAT vs RISEDRONATE